资讯

Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for Triple-Negative Breast Cancer ...